SciELO - Scientific Electronic Library Online

 
vol.22 número3Validación del cuestionario sobre la salud del paciente-9 (PHQ-9) en internos de medicina humana de una universidad de referencia del Perú durante la pandemia COVID-19Niveles de inteligencia emocional en estudiantes de la carrera de psicología de una universidad pública peruana índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista de la Facultad de Medicina Humana

versión impresa ISSN 1814-5469versión On-line ISSN 2308-0531

Resumen

PACHECO, Cristian; CALDERON, Mónica; BARRIONUEVO, Carlos  y  MORENO, Henry Gomez. Anaplastic large T-cell lymphoma: 10-year experience at the National Institute of Neoplastic diseases, Lima - Peru. Rev. Fac. Med. Hum. [online]. 2022, vol.22, n.3, pp.547-555.  Epub 09-Jul-2022. ISSN 1814-5469.  http://dx.doi.org/10.25176/rfmh.v22i3.5027.

Introduction:

Anaplastic Large T-Cell Lymphoma is an infrequent pathology, determined by the expression of CD30, with different characteristics in its presentation and being more aggressive according to ALK expression.

Objectives:

The present study seeks to determine the epidemiological, clinicopathological, and prognostic characteristics of patients with Anaplastic Large T-Cell Lymphoma.

Methods:

Descriptive, retrospective study of patients diagnosed with Anaplastic Large T-Cell Lymphoma of the National Institute of Neoplastic Diseases (INEN) between 2006 and 2016.

Results:

The pathology of 86 patients was analyzed and reviewed, 57% were men and 33 % women; of the total population, 21.9% were positive for ALK, 48 of the patients were found in CD I and II, and 36 between stages III and IV. 57 patients had low or low-intermediate risk, while 26 had high-intermediate and high risk. The estimated overall survival was 40.8% at 5 years; in the group of patients with ALK + it was 67.4%, and in the group with ALK-, it was estimated at 30.2%.

Conclusions:

Anaplastic Large T-Cell Lymphoma is an aggressive disease with a heterogeneous distribution to age and slightly more frequent in males, with ALK and the international prognostic index as important prognostic factors.

Palabras clave : Anaplastic Large Cell Lymphoma; Anaplastic Lymphoma Kinase; Survival rate. (fuente: MeSH NLM)..

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )